• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痛风的发病机制:探索更多的治疗靶点。

Pathogenesis of gout: Exploring more therapeutic target.

机构信息

First Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, China.

School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China.

出版信息

Int J Rheum Dis. 2024 Apr;27(4):e15147. doi: 10.1111/1756-185X.15147.

DOI:10.1111/1756-185X.15147
PMID:38644732
Abstract

Gout is a chronic metabolic and immune disease, and its specific pathogenesis is still unclear. When the serum uric acid exceeds its saturation in the blood or tissue fluid, it is converted to monosodium urate crystals, which lead to acute arthritis of varying degrees, urinary stones, or irreversible peripheral joint damage, and in severe cases, impairment of vital organ function. Gout flare is a clinically significant state of acute inflammation in gout. The current treatment is mostly anti-inflammatory analgesics, which have numerous side effects with limited treatment methods. Gout pathogenesis involves many aspects. Therefore, exploring gout pathogenesis from multiple perspectives is conducive to identifying more therapeutic targets and providing safer and more effective alternative treatment options for patients with gout flare. Thus, this article is of great significance for further exploring the pathogenesis of gout. The author summarizes the pathogenesis of gout from four aspects: signaling pathways, inflammatory factors, intestinal flora, and programmed cell death, focusing on exploring more new therapeutic targets.

摘要

痛风是一种慢性代谢和免疫性疾病,其具体发病机制尚不清楚。当血清尿酸超过血液或组织液中的饱和度时,会转化为单钠尿酸盐晶体,导致不同程度的急性关节炎、尿路结石或不可逆转的外周关节损伤,严重时还会损害重要器官的功能。痛风发作是痛风的一种具有临床意义的急性炎症状态。目前的治疗方法大多是抗炎镇痛药,但治疗方法有限,且有许多副作用。痛风的发病机制涉及多个方面。因此,从多个角度探讨痛风的发病机制有助于发现更多的治疗靶点,为痛风发作患者提供更安全、更有效的替代治疗选择。因此,本文对进一步探讨痛风的发病机制具有重要意义。作者从信号通路、炎症因子、肠道菌群和细胞程序性死亡四个方面总结了痛风的发病机制,重点探讨了更多新的治疗靶点。

相似文献

1
Pathogenesis of gout: Exploring more therapeutic target.痛风的发病机制:探索更多的治疗靶点。
Int J Rheum Dis. 2024 Apr;27(4):e15147. doi: 10.1111/1756-185X.15147.
2
Limitations of the Current Standards of Care for Treating Gout and Crystal Deposition in the Primary Care Setting: A Review.基层医疗环境中治疗痛风和晶体沉积的当前护理标准的局限性:一项综述
Clin Ther. 2017 Feb;39(2):430-441. doi: 10.1016/j.clinthera.2016.12.011. Epub 2017 Jan 11.
3
Therapeutic approaches in the treatment of gout.痛风治疗方法。
Semin Arthritis Rheum. 2020 Jun;50(3S):S24-S30. doi: 10.1016/j.semarthrit.2020.04.010.
4
A new perspective on the pharmacoeconomics of colchicine.秋水仙碱的药物经济学新视角。
Curr Med Res Opin. 2011 May;27(5):931-7. doi: 10.1185/03007995.2011.563284. Epub 2011 Mar 3.
5
The safety of treatment options available for gout.痛风现有治疗方案的安全性。
Expert Opin Drug Saf. 2017 Apr;16(4):429-436. doi: 10.1080/14740338.2017.1284199. Epub 2017 Jan 30.
6
Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities.痛风:关节及其他方面、流行病学、临床特征、治疗及合并症
Maturitas. 2014 Aug;78(4):245-51. doi: 10.1016/j.maturitas.2014.05.001. Epub 2014 May 14.
7
Gout and hyperuricemia.痛风与高尿酸血症。
Compr Ther. 2010;36:3-13.
8
[Crystal-induced arthritis--old but important].[晶体诱导性关节炎——古老却重要]
Z Rheumatol. 2007 Jul;66(4):317-24; quiz 325. doi: 10.1007/s00393-007-0177-1.
9
Gout.痛风。
Nat Rev Dis Primers. 2019 Sep 26;5(1):69. doi: 10.1038/s41572-019-0115-y.
10
Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker.痛风患者发作期、间歇期和达标治疗期的系统性炎症细胞因子谱:TNFSF14 作为新的生物标志物。
Ann Rheum Dis. 2024 Jun 12;83(7):945-956. doi: 10.1136/ard-2023-225305.

引用本文的文献

1
Decoding PANoptosis in Gout: Signature Gene Identification and Immune Infiltration Profiling.痛风中全程序性坏死的解码:特征基因鉴定与免疫浸润分析
Int J Rheum Dis. 2025 Jul;28(7):e70344. doi: 10.1111/1756-185X.70344.
2
The changing burden of gout in adults aged 70 and above based on the global burden of disease 2019.基于2019年全球疾病负担研究的70岁及以上成年人痛风负担变化情况
Front Public Health. 2025 Feb 6;13:1455726. doi: 10.3389/fpubh.2025.1455726. eCollection 2025.
3
Causal effects of gut microbiota on gout and hyperuricemia: insights from genome-wide Mendelian randomization, RNA-sequencing, 16S rRNA sequencing, and metabolomes.
肠道微生物群对痛风和高尿酸血症的因果关系:来自全基因组孟德尔随机化、RNA 测序、16S rRNA 测序和代谢组学的见解。
Biosci Rep. 2024 Nov 27;44(11). doi: 10.1042/BSR20240595.